These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21747385)

  • 1. Streamlining biomarker discovery.
    Latterich M; Schnitzer JE
    Nat Biotechnol; 2011 Jul; 29(7):600-2. PubMed ID: 21747385
    [No Abstract]   [Full Text] [Related]  

  • 2. A targeted proteomics-based pipeline for verification of biomarkers in plasma.
    Whiteaker JR; Lin C; Kennedy J; Hou L; Trute M; Sokal I; Yan P; Schoenherr RM; Zhao L; Voytovich UJ; Kelly-Spratt KS; Krasnoselsky A; Gafken PR; Hogan JM; Jones LA; Wang P; Amon L; Chodosh LA; Nelson PS; McIntosh MW; Kemp CJ; Paulovich AG
    Nat Biotechnol; 2011 Jun; 29(7):625-34. PubMed ID: 21685906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
    Addona TA; Shi X; Keshishian H; Mani DR; Burgess M; Gillette MA; Clauser KR; Shen D; Lewis GD; Farrell LA; Fifer MA; Sabatine MS; Gerszten RE; Carr SA
    Nat Biotechnol; 2011 Jun; 29(7):635-43. PubMed ID: 21685905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
    Rifai N; Gillette MA; Carr SA
    Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ensemble strategy for classification of prostate cancer protein mass spectra.
    Assareh A; Moradi MH; Esmaeili V
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5988-91. PubMed ID: 18003378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intersession reproducibility of mass spectrometry profiles and its effect on accuracy of multivariate classification models.
    Pelikan R; Bigbee WL; Malehorn D; Lyons-Weiler J; Hauskrecht M
    Bioinformatics; 2007 Nov; 23(22):3065-72. PubMed ID: 17766268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
    J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-S: a directed mass spectrometry method for biomarker verification in native serum.
    Yin HR; Xie LQ; Xu Y; Cai SJ; Yao J; Yang PY; Lu HJ
    Analyst; 2015 May; 140(10):3654-62. PubMed ID: 25873488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mass spectral serum profiles for biomarker selection.
    Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SA; Saha D; Goldman L; Petricoin EF; Conrads TP; Veenstra TD; Loffredo CA; Goldman R
    Bioinformatics; 2005 Nov; 21(21):4039-45. PubMed ID: 16159919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.
    Röwer C; Koy C; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
    J Am Soc Mass Spectrom; 2011 Mar; 22(3):440-56. PubMed ID: 21472563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stress test for mass spectrometry-based proteomics.
    Aebersold R
    Nat Methods; 2009 Jun; 6(6):411-2. PubMed ID: 19448640
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteome maps of the main human peripheral blood constituents.
    Haudek VJ; Slany A; Gundacker NC; Wimmer H; Drach J; Gerner C
    J Proteome Res; 2009 Aug; 8(8):3834-43. PubMed ID: 19580323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early cancer diagnosis through proteomics of serum: fiction or fact?].
    Zapico Muñiz E; Mora Brugés J; Blanco Vaca F
    Med Clin (Barc); 2005 Feb; 124(5):181-5. PubMed ID: 15725370
    [No Abstract]   [Full Text] [Related]  

  • 14. Confounding effects of hormone replacement therapy in protein biomarker studies.
    Pitteri SJ; Hanash SM
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):134-9. PubMed ID: 21037107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based expression profiling of clinical prostate cancer.
    Wright ME; Han DK; Aebersold R
    Mol Cell Proteomics; 2005 Apr; 4(4):545-54. PubMed ID: 15695425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valid data from large-scale proteomics studies.
    Chamrad D; Meyer HE
    Nat Methods; 2005 Sep; 2(9):647-8. PubMed ID: 16118632
    [No Abstract]   [Full Text] [Related]  

  • 17. Peptides you can count on.
    Bergeron JJ; Hallett M
    Nat Biotechnol; 2007 Jan; 25(1):61-2. PubMed ID: 17211399
    [No Abstract]   [Full Text] [Related]  

  • 18. New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Guo R; Pan C; Shen J; Liu C
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):513-9. PubMed ID: 20490864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in neurosciences.
    Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
    Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.